1. Home
  2. SPRO vs SOTK Comparison

SPRO vs SOTK Comparison

Compare SPRO & SOTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

SELL

Current Price

$1.10

Market Cap

67.0M

Sector

Health Care

ML Signal

SELL

Logo Sono-Tek Corporation

SOTK

Sono-Tek Corporation

SELL

Current Price

$6.16

Market Cap

72.1M

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
SPRO
SOTK
Founded
2013
1975
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
67.0M
72.1M
IPO Year
2017
1995

Fundamental Metrics

Financial Performance
Metric
SPRO
SOTK
Price
$1.10
$6.16
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$5.00
★ $8.50
AVG Volume (30 Days)
★ 839.8K
134.1K
Earning Date
11-12-2026
10-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 111.81
37.50
EPS
N/A
★ 0.07
Revenue
★ $66,802,000.00
$20,909,315.00
Revenue This Year
N/A
$2.59
Revenue Next Year
N/A
$23.41
P/E Ratio
★ N/A
$87.21
Revenue Growth
★ 39.24
1.97
52 Week Low
$1.08
$3.40
52 Week High
$3.08
$7.48

Technical Indicators

Market Signals
Indicator
SPRO
SOTK
Relative Strength Index (RSI) 41.51 53.94
Support Level $1.10 $4.07
Resistance Level $1.28 $7.48
Average True Range (ATR) 0.06 0.68
MACD -0.01 -0.02
Stochastic Oscillator 2.50 47.89

Price Performance

Historical Comparison
SPRO
SOTK

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About SOTK Sono-Tek Corporation

Sono-Tek Corp designs and manufactures ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial, and emerging research & development/other markets. The company designs and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

Share on Social Networks: